This review assessed the diagnostic accuracy of ultrasonography in newborn infants for developmental dysplasia of the hip. The authors found only one diagnostic accuracy study and concluded that there was a lack of evidence either for or against the use of ultrasound screening. The review was well-conducted and its conclusions are likely to be reliable.
Data extraction
One reviewer extracted the data, which a second reviewer checked. Where appropriate, treatment differences were calculated as the mean difference or absolute risk difference, along with the corresponding 95% confidence interval (CI).
Methods of synthesis
How were the studies combined? The studies were combined in a narrative.
How were differences between studies investigated?
The studies were grouped according to study design and outcomes.
Results of the review
Ten studies were included: one diagnostic accuracy study using a historical control group (n=7,236), 2 RCTs (n=28,554), and 7 non-randomised studies (the numbers were unclear in 2 studies and ranged from 1,422 to 89,200 in the other 5 studies).
One diagnostic accuracy study, which used a reference standard that was not independent of the index test and might not have identified the target condition, reported a sensitivity of 88.5% (95% CI: 84.1, 92.1) and a specificity of 96.7% (95% CI: 96.4, 97.4) for ultrasonography.
The quality of the 10 studies (including the diagnostic accuracy study) reporting on the impact of ultrasonography on other clinical outcomes was limited. Six out of 7 studies reported an increase in overall treatment rate with ultrasonography. One of 2 studies reported a reduction in the duration of treatment after ultrasonography, while the other reported that screening at birth led to shorter treatment duration than screening at 3 to 4 months.
Two RCTs compared the prevalence of late (after 1 month) diagnosis of DDH after ultrasonography plus clinical screening with clinical screening alone, and found lower rates (although not statistically significant) after ultrasonography. Another study defined late diagnosis as diagnosis after 8 months and found similar rates of 'missed' cases for ultrasonography compared with clinical screening.
Authors' conclusions
There was insufficient evidence for the diagnostic accuracy of ultrasonography as a screening tool for DDH in newborns.
CRD commentary
This review had a comprehensive literature search with no language restrictions, thereby reducing the risk of publication and language bias. The inclusion criteria were clear. An appropriate quality assessment was performed and all steps of the review were performed in duplicate, which minimised the chances of bias being introduced. The narrative review was appropriate given the small number of studies of different designs. This was a well-conducted review and its conclusions are likely to be reliable given the quality and quantity of the primary studies.
Implications of the review for practice and research
Practice: The authors stated that ultrasound screening could not yet be recommended.
Research: The authors stated that good-quality trials to establish the optimum treatment and management of DDH are needed. An RCT incorporating the optimum treatment and management of DDH and comparing screening at 1 and 3
